CRYSTALLINE FORMS OF (S)-1-(4-(5-CYCLOPROPYL-1H-PYRAZOL-3-YLAMINO)PYRROLO[1,2-f][1,2,4]TRIAZIN-2-YL)-N-(6-FLUOROPYRIDIN-3-YL)-2-METHYLPYRROLIDINE-2-CARBOXAMIDE
    6.
    发明申请
    CRYSTALLINE FORMS OF (S)-1-(4-(5-CYCLOPROPYL-1H-PYRAZOL-3-YLAMINO)PYRROLO[1,2-f][1,2,4]TRIAZIN-2-YL)-N-(6-FLUOROPYRIDIN-3-YL)-2-METHYLPYRROLIDINE-2-CARBOXAMIDE 失效
    (S)-1-(4-(5-环丙基)-1H-吡唑-3-基]氨基]吡咯并[1,2-f] [1,2,4]三嗪-2-基)-N-( 6-氟吡啶-3-基)-2-甲基吡咯烷-2-羧酸酰胺

    公开(公告)号:US20120302571A1

    公开(公告)日:2012-11-29

    申请号:US13576973

    申请日:2011-02-03

    CPC分类号: C07D487/04

    摘要: Crystalline forms of (S)-1-(4-(5-cyclopropyl-1H-pyrazol-3-ylamino)pyrrolo[1,2-f][1,2,4]triazin-2-yl)-N-(6-fluoropyridin-3-yl)-2-methylpyrrolidine-2-carboxamide of the formula (I) are provided. Also provided is a pharmaceutical composition comprising one or more crystalline forms of (3R,4R)-4-amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol, as well as a method of using one or more crystalline forms of (3R,4R)-4-amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol in the treatment of cancer and other proliferative diseases.

    摘要翻译: (S)-1-(4-(5-环丙基-1H-吡唑-3-基氨基)吡咯并[1,2-f] [1,2,4]三嗪-2-基)-N-( 6-氟吡啶-3-基)-2-甲基吡咯烷-2-甲酰胺。 还提供了包含一种或多种结晶形式的(3R,4R)-4-氨基-1 - [[4 - [(3-甲氧基苯基)氨基]吡咯并[2,1-f] [1,2, 4]三嗪-5-基]甲基]哌啶-3-醇,以及使用一种或多种结晶形式的(3R,4R)-4-氨基-1 - [[4 - [(3-甲氧基苯基) )氨基]吡咯并[2,1-f] [1,2,4]三嗪-5-基]甲基]哌啶-3-醇用于治疗癌症和其它增殖性疾病。